Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving antigen-antibody binding – specific binding protein...
Patent
1998-04-09
2000-10-24
Navarro, Mark
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving antigen-antibody binding, specific binding protein...
435 792, 435 794, 435 795, 435 405, 435 4052, 436503, G01N 3353, G01N 130, G01N 33567
Patent
active
061365467
ABSTRACT:
Disclosed are compositions and methods for aiding in the diagnosis of congenital muscular dystrophy associated with in-frame deletion in the laminin-2 .alpha.2 polypeptide chain in an individual. In a preferred diagnostic method embodiment, an experimental muscle tissue sample is provided from the individual and treated if necessary to render components available for antibody binding. The components of the sample are then separated on the basis of molecular weight. The separated protein components are then transferred to a solid support while maintaining the relative positions established in separation step. The transferred components are then stained with an affinity reagent which is known to bind to a C-terminal domain of the laminin-2 .alpha.2 polypeptide chain. Individual afflicted with congenital muscular dystrophy associated with in-frame deletion in the laminin-2 .alpha.2 polypeptide chain on the basis of positive staining in combination with reduced molecular weight of the laminin-2 .alpha.2 polypeptide chain relative to the wild-type laminin-2 .alpha.2 polypeptide chain. A preferred composition is a nucleic acid probe for the detection of merosin deletion-type congenital muscular dystrophy. The preferred nucleic acid probe is characterized by the ability to bind specifically to a mutant merosin nucleic acid sequence, the mutant merosin nucleic acid sequence comprising a T to C substitution at position 3973 +2 of the consensus donor splice site of exon 25.
REFERENCES:
Leivo L et al PNAS 85:1544-1548, 1988.
Engvall E et al. J Cell Biol 103:2457-2465, 1986.
Helbling-Leclerc et al., Nat. Genet. 11: 216-218 (1995).
Nissinen et al., Am. J. Hum. Genet. 58: 1177-1184 (1996).
Fardeau et al., Rev. Neurol. (Paris) 152: 11-19 (1996).
Sunada et al., Hum. Mol. Gent. 4: 1055-1061 (1995).
Xu et al., Nat. Genet. 8: 297-301 (1994).
Zhang et al., J. Biol Chem. 271: 27664-27669 (1996).
Allamand et al., Hum. Mol. Genet. 6: 747-752 (1997).
Allamand Valerie
Campbell Kevin P.
Salih Mustafa
Straub Volker
Sunada Yoshihide
Farrell Kevin M.
Lee Li
Navarro Mark
University of Iowa Research Foundation
LandOfFree
Method for aiding in the diagnosis of in-frame deletion type con does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for aiding in the diagnosis of in-frame deletion type con, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for aiding in the diagnosis of in-frame deletion type con will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1962193